JT
ABVX

Jupiter Topco’s Abivax ABVX Stock Holding History

Jupiter Topco’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$255M Buy
+1,913,933
New +$217M 0.1% 184

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $3.35B AUM 55.08% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Jupiter Topco's ABVX Position: Q2 2026 in Review

Jupiter Topco opened a new position in Abivax (ABVX) in Q2 2026: 1,913,933 shares worth $255M. The stake represents 0.1% of the portfolio and ranks #184 among its holdings.

275 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Jupiter Topco held 1,913,933 shares of Abivax worth $255M as of Q2 2026.
  • Abivax was a new Jupiter Topco position in Q2 2026.
  • Abivax made up 0.1% of Jupiter Topco's portfolio in Q2 2026, its #184 holding.
  • 275 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.